MARISA PARAND: Open Payments
NPI 1992396030 · HOLBROOK, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,370 in 57 payments from 15 companies in 2025. Trend: 2023 $179 · 2024 $1,050 · 2025 $1,370
Food & beverage: $1,298Education: $72
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 8 | $451 |
| Galderma Laboratories, L.P. | 26 | $234 |
| Arcutis Biotherapeutics, Inc. | 2 | $161 |
| SANOFI-AVENTIS U.S. LLC | 1 | $72 |
| ABBVIE INC. | 3 | $66 |
| PFIZER INC. | 3 | $66 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $64 |
| Novartis Pharmaceuticals Corporation | 2 | $58 |
| Janssen Biotech, Inc. | 2 | $48 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 2 | $36 |
Products named: DUPIXENT, AKLIEF, Zoryve, Winlevi, TREMFYA, CIBINQO, Cabtreo, COSENTYX.
Industry payments across MA — which companies pay providers there.
